None listed
Conditions
Brief summary
The purpose of the study is to assess the efficacy of smartwatches to investigate patients with palpitations. These are commonly worn by members of the general public, and because they are worn continuously may be able to capture an ECG at the time of palpitations. This may have a benefit over Holter monitors, as these are only worn for a 24-hour period - therefore if the palpitations occur outside the 24-hour monitoring period, patients will not receive a diagnosis.
Interventions
Patients with palpitations will be randomised to 2 groups.
1. Control: Investigation with a 24-hour Holter monitor (current standard of care)
2. Intervention: Monitoring with a smartwatch with ECG capabilities (e.g. Fitbit, Applewatch or Withings Scanwatch). Patients will be able to use their own smartwatch. If they do not own one, one will be supplied to them by the study investigators. The duration of monitoring will be 3-months. They will be instructed to take an ECG during an episode of palp
Patients with palpitations will be randomised to 2 groups. 1. Control: Investigation with a 24-hour Holter monitor (current standard of care) 2. Intervention: Monitoring with a smartwatch with ECG capabilities (e.g. Fitbit, Applewatch or Withings Scanwatch). Patients will be able to use their own smartwatch. If they do not own one, one will be supplied to them by the study investigators. The duration of monitoring will be 3-months. They will be instructed to take an ECG during an episode of palpitations, and therefore they do not need to wear it if asymptomatic. We will not collect any other data from the smartwatches beyond patient transmitted ECGs. These ECGs will be obtained via the smartwatch
Sponsors
Box Hill Hospital
Study design
Allocation
Randomised controlled trial
Primary purpose
Diagnosis
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Age greater than or equal to 18 years of age Presentation to an ED or a cardiology outpatient clinic with palpitations as the presenting problem
Exclusion criteria
<18 years of age Patients unable to provide their own consent to participate Patients unable to operate a smartwatch (e.g. vision impairment, deforming arthritis) Patients in whom a symptom-rhythm correlation has already been identified (e.g. via previous Holter) Syncope Cardiac arrest
Outcome results
None listed